AccessPak for HIV PEP Expanded with Kaletra and Pegvisomant Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Pegvisomant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: pegvisomant
Brand name: Somavert
Synonyms: Pegvisomant
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Pembrolizumab
- AccessPak for HIV PEP Expanded with Kaletra-Pembrolizumab Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Pemetrexed
- AccessPak for HIV PEP Expanded with Kaletra-Pemetrexed Disodium
- AccessPak for HIV PEP Expanded with Kaletra-Pemetrexed Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Pemoline
- Pegvisomant Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Pegvisomant Subcutaneous-Accolate
- Pegvisomant Subcutaneous-Accretropin
- Pegvisomant Subcutaneous-Accucaine
- Pegvisomant Subcutaneous-AccuHist Drops
- Pegvisomant Subcutaneous-AccuHist PDX Drops